Dosage and administration of non-fucosylated anti-CD40 antibodies
US11202827B2 · kind B2 · utility
0Cited by
13References
170Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jan 20, 2017 |
| Grant date | Dec 21, 2021 |
| Priority date | — |
| Expiry date | Jan 2, 2038 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2317/92
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
This invention relates methods of using a non-fucosylated anti-CD40 antibody for treatment of cancer and chronic infectious diseases.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.